Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: Proposal of an international research group

Authors

Nima Etminan, Heinrich-Heine-Universität Düsseldorf
Kerim Beseoglu, Heinrich-Heine-Universität Düsseldorf
Daniel L. Barrow, Emory University School of Medicine
Joshua Bederson, Sinai Health System
Robert D. Brown, Mayo Clinic
E. Sander Connolly, Columbia University
Colin P. Derdeyn, Washington University School of Medicine in St. Louis, Mallinckrodt Institute of Radiology
Daniel Hänggi, Heinrich-Heine-Universität Düsseldorf
David Hasan, University of Iowa
Seppo Juvela, Helsingin Yliopisto
Hidetoshi Kasuya, Tokyo Women's Medical University Hospital
Peter J. Kirkpatrick, Cambridge University Hospitals NHS Foundation Trust
Neville Knuckey, Sir Charles Gairdner Hospital
Timo Koivisto, Kuopio University Hospital
Giuseppe Lanzino, Mayo Clinic
Michael T. Lawton, University of California, San FranciscoFollow
Peter Leroux, Lankenau Institute for Medical Research
Cameron G. McDougall, Barrow Neurological Institute
Edward Mee, Auckland City Hospital
J. Mocco, Vanderbilt University Medical Center
Andrew Molyneux, University of Oxford Medical Sciences Division
Michael K. Morgan, Macquarie University
Kentaro Mori, National Defense Medical College Tokorozawa
Akio Morita, Nippon Medical School
Yuichi Murayama, The Jikei University School of Medicine
Shinji Nagahiro, Tokushima University
Alberto Pasqualin, Università degli Studi di Verona
Andreas Raabe, University Hospital Bern
Jean Raymond, Hôpital Notre-Dame
Gabriel J.E. Rinkel, University Medical Center Utrecht
Daniel Rüfenacht, Klinik Hirslanden
Volker Seifert, Goethe-Universität Frankfurt am Main

Document Type

Article

Abstract

BACKGROUND AND PURPOSE-: To address the increasing need to counsel patients about treatment indications for unruptured intracranial aneurysms (UIA), we endeavored to develop a consensus on assessment of UIAs among a group of specialists from diverse fields involved in research and treatment of UIAs. METHODS-: After composition of the research group, a Delphi consensus was initiated to identify and rate all features, which may be relevant to assess UIAs and their treatment by using ranking scales and analysis of inter-rater agreement (IRA) for each factor. IRA was categorized as very high, high, moderate, or low. RESULTS-: Ultimately, 39 specialists from 4 specialties agreed (high or very high IRAs) on the following key factors for or against UIA treatment decisions: (1) patient age, life expectancy, and comorbid diseases; (2) previous subarachnoid hemorrhage from a different aneurysm, family history for UIA or subarachnoid hemorrhage, nicotine use; (3) UIA size, location, and lobulation; (4) UIA growth or de novo formation on serial imaging; (5) clinical symptoms (cranial nerve deficit, mass effect, and thromboembolic events from UIAs); and (6) risk factors for UIA treatment (patient age and life expectancy, UIA size, and estimated risk of treatment). However, IRAs for features rated with low relevance were also generally low, which underlined the existing controversy about the natural history of UIAs. CONCLUSIONS-: Our results highlight that neurovascular specialists currently consider many features as important when evaluating UIAs but also highlight that the appreciation of natural history of UIAs remains uncertain, even within a group of highly informed individuals. © 2014 American Heart Association, Inc.

Publication Date

1-1-2014

Publication Title

Stroke

ISSN

00392499

E-ISSN

15244628

Volume

45

Issue

5

First Page

1523

Last Page

1530

PubMed ID

24668202

Digital Object Identifier (DOI)

10.1161/STROKEAHA.114.004519

This document is currently not available here.

Share

COinS